Champions Oncology, Inc. (CSBR)

NASDAQ: CSBR · Real-Time Price · USD

6.44

-0.38 (-5.57%)

At close: Jun 18, 2026, 4:00 PM EDT

6.32

-0.12 (-1.86%)

After-hours: Jun 18, 2026, 4:00 PM EDT

Champions Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 18, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Market Cap	89	99	66	67	104	144
Market Cap Growth	1.40%	49.41%	-1.06%	-35.83%	-27.85%	46.50%
Enterprise Value	91.61	94.83	70.74	65.12	104.31	148.85
Last Close Price	6.44	7.15	4.85	4.92	7.68	10.73
PE Ratio	-	21.67	-	-	192.00	536.50
Forward PE	-	119.17	-	-	42.95	77.31
PEG Ratio	-	-	-	-	5.44	5.44
PS Ratio	1.62	1.73	1.31	1.24	2.11	3.51
PB Ratio	22.11	26.12	-34.65	14.37	11.42	19.38
P/TBV Ratio	22.79	29.68	-	15.49	12.41	22.05
P/FCF Ratio	24.56	14.08	-	60.58	25.25	-
P/OCF Ratio	21.33	13.34	-	16.78	15.98	-
EV/Sales Ratio	1.58	1.67	1.41	1.21	2.12	3.63
EV/EBITDA Ratio	-	15.31	-	-	46.69	96.03
EV/EBIT Ratio	-	20.83	-	-	171.85	406.69
EV/FCF Ratio	24.01	13.55	-	59.20	25.36	-
Debt / Equity Ratio	0.77	1.23	-3.20	1.59	0.92	1.18
Debt / EBITDA Ratio	-	0.99	-	-	4.24	6.19
Debt / FCF Ratio	-	0.87	-	7.82	2.30	-
Net Debt / Equity Ratio	-0.52	-0.98	-2.53	-0.33	0.05	0.66
Net Debt / EBITDA Ratio	0.85	-0.59	-0.88	0.51	0.21	3.17
Net Debt / FCF Ratio	-	-0.53	-0.69	-1.38	0.11	-0.99
Asset Turnover	4.07	1.95	1.66	1.55	1.56	1.70
Quick Ratio	0.34	0.41	0.56	0.83	1.06	1.04
Current Ratio	0.98	0.94	0.63	0.90	1.13	1.13
Return on Equity (ROE)	-107.03%	503.05%	-532.46%	-77.70%	6.63%	5.78%
Return on Assets (ROA)	-19.02%	15.82%	-24.23%	-15.28%	1.81%	1.25%
Return on Invested Capital (ROIC)	-27.24%	17.42%	-26.60%	-18.71%	2.28%	1.70%
Return on Capital Employed (ROCE)	-67.57%	69.61%	-85.69%	-34.49%	3.54%	2.95%
Earnings Yield	-	4.62%	-	-	0.52%	0.19%
FCF Yield	4.07%	7.10%	-	1.65%	3.96%	-
Buyback Yield / Dilution	1.39%	-5.31%	-0.04%	4.37%	2.84%	-23.05%
Total Shareholder Return	1.39%	-5.31%	-0.04%	4.37%	2.84%	-23.05%

SEC Filings: 10-K · 10-Q